Welcome to the iCAD Investors Page
The company's common stock is listed on the NASDAQ Stock Market under the symbol "ICAD".
Investor Presentation
To access a copy of the investor presentation, please see below.
Investor Presentation
Quick Links
Investor Relations
Media Inquiries
Recent Press Releases
September 15, 2020
iCAD Announces Compelling Data Supporting Launch of First and Only Commercially Available Technology to Provide Short-Term Breast Cancer Risk Assessment
September 9, 2020
iCAD Hosts Free Virtual Roundtable Event Focusing on Making Informed Decisions for Adopting New AI Solutions and Practical Applications in Healthcare
August 27, 2020
iCAD to Present at the LD Micro 500 Virtual Conference
August 10, 2020
iCAD to Participate in the Guggenheim MedTech Disruptors Summit
August 4, 2020
iCAD Reports Financial Results for Second Quarter and Six Months Ended June 30, 2020
July 20, 2020
iCAD Appoints Jeffrey Sirek as Senior Vice President and General Manager of Xoft
iCAD, Inc.
603.882.5200
pr@icadmed.com
iCAD is committed to corporate sustainability and to making a difference for our environment.
Recent Events and Webcasts
September 1-4, 202011:00 am ET - Track 4
iCAD to Present at the LD Micro 500 Virtual Conference
August 4, 20204:30 pm ET
iCAD to Report Second Quarter 2020 Financial Results on Tuesday, August 4
May 11, 20204:30 pm ET
iCAD to Report First Quarter 2020 Financial Results on Monday, May 11
March 4, 20208:00 am ET
iCAD to Participate in the 40th Annual Cowen Healthcare Conference
February 27, 20204:30 pm ET
iCAD To Report Fourth Quarter 2019 Financial Results
Resources
Precise and Powerful Healthcare Solutions
© 2020, iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.